Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL),
a leading air purification technology company, today announced the
launch of Molekule 360, a first-of-its-kind indoor air quality
(“IAQ”) management solution.
Proactive adopters, including Carr
Properties, ITVS, Rancho Valencia, Sacred Heart Academy, Salesforce
and one of the four largest U.S. banks, have made significant
investments to ensure safer indoor environments, while also
cost-effectively complying with CDC, EPA, and American Society of
Heating, Refrigerating and Air-Conditioning Engineers guidance.
Notably, Salesforce purchased and deployed approximately 3,000
Molekule devices over the last two years across 30 locations
throughout the U.S. and Canada.
Molekule 360 was created for
enterprise-wide deployment to provide monitoring and control of
thousands of Internet of Things (“IoT”) enabled devices from a
single location, across multiple facilities and cities, as
employers, like Salesforce, navigate the increased importance of
IAQ with workers returning to in-person offices in higher
volumes.
The comprehensive indoor air quality management solution is an
intuitive, easy-to-use platform that provides real-time, AI-enabled
IAQ insights across an organization’s building portfolio. With
weather intelligence features supported by integration with
satellites from our partner Tomorrow.io, Molekule 360 can forecast
outdoor factors such as wildfire smoke, pollen count, pollution
levels, ozone and more, empowering organizations with actionable
information to proactively safeguard the health and safety of
building occupants.
Molekule 360 provides the following benefits:
- 24/7 peace of mind: Molekule 360 constantly
tracks IAQ data and outdoor impacts to automate air purification
device fleet response and address air quality concerns in real time
on a room-by-room and building-by-building basis for enterprise
customers.
- Immediate AI-enabled insights: Built around
the Molekule 360 Hub connected dashboard, the platform connects to
existing building management systems (“BMS”) and other connected
platforms using the Molekule API. Molekule 360’s real-time data and
analysis capabilities allow organizations to gain up-to-the-minute
information on IAQ parameters like particulate matter, harmful
airborne pathogens, carbon dioxide, volatile organic compounds,
humidity and temperature, facilitating prompt actions and
optimizations.
- Seamless connectivity: Enabled by the Internet
of Things, Molekule 360 connects to existing BMS and other
IoT-enabled systems to enable comprehensive situational awareness
of IAQ parameters and trends, driving proactive measures and timely
interventions.
- Native enterprise control: Molekule 360
features built-in support for thousands of Molekule purifiers
enabling monitoring and automatic air quality management right out
of the box and from a single location.
- Scientifically proven protection: Molekule’s
proprietary photoelectrochemical oxidation, or PECO, technology
helps protect indoor air from harmful viruses, bacteria, mold,
toxic chemicals, wildfire smoke, hazardous particulate matter and
other pollutants.
“We recognize that indoor
air quality directly impacts the health and well-being of building
occupants — and is an increasingly vital component of healthy
building initiatives. In the U.S., many of us spend approximately
90% of our lives indoors, so measuring, treating and controlling
indoor air helps combat pollutants and other harmful microorganisms
to make the air we breathe cleaner,” said Jason DiBona, CEO of
Molekule. “By driving real-time decision-making at granular levels,
the Molekule 360 platform truly transforms how organizations across
industries create safer indoor air environments for employees,
patients, students, customers and beyond.”
Molekule 360 is a unique solution which utilizes Molekule air
purifiers, satellite-based weather data powered by Tomorrow.io and
AI-driven analysis to assess the connection between outdoor
environments and their influence on IAQ and operational well-being.
Decision-makers can leverage the information to create rules and
set real-time notifications when IAQ parameters meet certain
thresholds.
“Implementing Molekule 360 has revolutionized our approach to
indoor air quality management,” said Ilan Zachar, chief technology
officer at Carr Properties. “Studies have correlated higher IAQ
with a rise in employee satisfaction, better productivity,
performance and morale, in addition to enhanced energy efficiency.
Across the Carr Properties portfolio of commercial office spaces,
we are committed to providing a consistently safe environment for
everyone in our building communities. The Molekule solution allows
us to monitor each room and common space to make real-time
decisions that ensure a healthier, more productive working
environment.”
Molekule has one of the
largest ranges of proprietary and patented Food and Drug
Administration-cleared air purification devices.
Molekule believes that
its patented PECO technology is one of a kind in its capability to
not only capture but break down pollutants like bacteria, viruses,
mold, allergens and more. Molekule devices are the only air
purifiers to use patented PECO technology to destroy
pollutants.
If you are interested in
a quote for your organization, please inquire at
molekule.com/business.
About
MolekuleReferences to “Molekule” herein include Molekule
Group, Inc. (Nasdaq: MKUL) and its consolidated subsidiaries,
including Molekule, Inc. Molekule is creating safer, healthier
indoor environments worldwide, starting with our most essential
resource: the air we breathe. Based on over 25 years of research
and development, the company creates scientifically proven
technology to improve indoor air quality for individuals,
businesses, schools, hospitals and organizations of all sizes.
Molekule's lineup of air purification solutions incorporates
medical-grade high-efficiency particulate air filtration and the
company’s patented photoelectrochemical oxidation (PECO)
technology, which surpasses traditional filters by effectively
destroying a wide range of pollutants, including volatile organic
compounds, mold, bacteria, viruses and allergens. These devices
have undergone rigorous assessments and validations by third-party
laboratories, earning FDA clearance as medical devices. It’s all
part of Molekule’s vision of changing the world from the indoors
out. For more details, please visit molekule.com.
Forward-Looking
Statements
This press release contains
“forward-looking statements” within the meaning of the “safe
harbor” provisions of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements are based upon current
beliefs and expectations of our management and are subject to known
and unknown risks and uncertainties. Words or expressions such as
“expects,” “anticipates,” “intends,” “plans,” “believes,”
“estimates,” “may,” “will,” “projects,” “could,” “should,” “would,”
“seek,” “forecast,” or other similar expressions help identify
forward-looking statements. Factors that could cause actual events
to differ include, but are not limited to:
- general economic conditions in the markets where we
operate;
- the impact of the COVID-19 pandemic and related prophylactic
measures;
- expected timing of regulatory approvals and product
launches;
- non-performance of third-party vendors and contractors;
- risks related to our ability to successfully sell our products
and the market reception to and performance of our products;
- the possibility that our products do not ultimately perform in
line with our testing or that prior test results may not be
replicated in future studies;
- our compliance with, and changes to, applicable laws and
regulations;
- our limited operating history;
- our ability to manage growth;
- our ability to obtain additional financing when and if
needed;
- our ability to expand product offerings;
- our ability to compete with others in our industry;
- our ability to protect our intellectual property;
- the ability of certain stockholders to determine the outcome of
matters that require stockholder approval;
- our ability to retain the listing of our common stock on
Nasdaq;
- our ability to defend against legal proceedings;
- success in retaining or recruiting, or changes required in, our
officers, key employees or directors;
- the risk that the merger between Molekule and Aura may not be
completed; and
- other economic, business, competitive, and regulatory factors
affecting the businesses of the Company generally, including but
not limited to those set forth in Molekule’s filings with the SEC,
including in the “Risk Factors” and “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” sections
of Molekule’s latest annual report on Form 10-K, as amended, and
other SEC filings.
Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties, and actual results may differ materially from those
in the forward-looking statements as a result of various factors.
Although we believe that the expectations reflected in the
forward-looking statements are reasonable based on information
currently available, we cannot assure you that the expectations
will prove to have been correct. Accordingly, you should not place
undue reliance on these forward-looking statements. In any event,
these statements speak only as of the date of this release. We
assume no obligation to revise or update any of the forward-looking
statements to reflect events or circumstances after the date of
this release or to reflect new information or the occurrence of
unanticipated events.
Media ContactPress@molekule.com
Investor Relations ContactsRyan
TylerChief Financial Officer, MolekuleRyan.Tyler@molekule.com
MATTIO
Communicationsmolekule@mattio.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/890697e8-7d49-49ff-8787-5716230ecb10
Grafico Azioni Molekule (NASDAQ:MKUL)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Molekule (NASDAQ:MKUL)
Storico
Da Dic 2023 a Dic 2024